Association between metabolic syndrome and risk of incident low back pain: A retrospective cohort study using real-world data from Japan

TL;DR

This study found that metabolic syndrome increases the risk of developing low back pain, using real-world data from Japan.

Contribution

The study provides new evidence linking metabolic syndrome to incident low back pain using longitudinal real-world data.

Findings

Metabolic syndrome was associated with a 24% higher risk of incident low back pain.

Females with metabolic syndrome had a higher risk increase compared to males.

Abdominal obesity combined with other metabolic components further increased low back pain risk.

Abstract

Obesity is a well-established risk factor for low back pain (LBP). Emerging evidence suggests that other metabolic abnormalities may also be associated with LBP; however, the association between metabolic syndrome (MetS) and LBP remains unclear. This study assessed the association of MetS with the risk of incident LBP using longitudinal real-world data from Japan.

Health insurance claims and health checkup data from prefectural government employees across all Japanese prefectures except Tokyo (April 1, 2018–March 31, 2023) were linked. Incident LBP was identified from claims, and MetS status from checkups. Participants who underwent a health checkup between April 1, 2018 and March 31, 2019 with no LBP that year were followed from April 1, 2019 to March 31, 2023. Cox proportional hazards models estimated hazard ratios (HRs) and 95 % confidence intervals (CIs) to explore the association of MetS with LBP risk.

Among 111,095 participants (mean follow-up: 3.3 years, 362,911.7 person-years), 16,894 developed LBP (15.2 %). MetS was associated with a significantly higher LBP risk (HR = 1.24; 95 % CI, 1.19–1.30). In sex-stratified analyses, the HR was 1.23 (95 % CI, 1.17–1.29) for males and 1.34 (95 % CI, 1.17–1.54) for females. Participants with abdominal obesity with additional MetS components had a greater LBP risk than those with abdominal obesity alone.

MetS may be a predictor of incident LBP, highlighting the potential value of MetS management in LBP prevention.

•Metabolic syndrome was associated with an increased risk of incident low back pain.•Abdominal obesity with additional metabolic components increased low back pain risk.•Analysis of real-world data enabled longitudinal estimation of low back pain risk.

Metabolic syndrome was associated with an increased risk of incident low back pain.

Abdominal obesity with additional metabolic components increased low back pain risk.

Analysis of real-world data enabled longitudinal estimation of low back pain risk.

Figures